Go Pro

Thryv (THRY) Competitors

Thryv logo
$1.52 -0.05 (-3.18%)
Closing price 04:00 PM Eastern
Extended Trading
$1.54 +0.02 (+1.64%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

THRY vs. XNET, SVCO, LAW, CMRC, and DMAA

Should you buy Thryv stock or one of its competitors? Thryv's main competitors and comparable companies include Xunlei (XNET), Silvaco Group (SVCO), CS Disco (LAW), Commerce.com (CMRC), and Drugs Made In America Acquisition (DMAA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Thryv compare to Xunlei?

Xunlei (NASDAQ:XNET) and Thryv (NASDAQ:THRY) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Xunlei has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market. Comparatively, Thryv has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

5.1% of Xunlei shares are held by institutional investors. Comparatively, 96.4% of Thryv shares are held by institutional investors. 21.7% of Xunlei shares are held by insiders. Comparatively, 10.5% of Thryv shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Xunlei has higher earnings, but lower revenue than Thryv. Thryv is trading at a lower price-to-earnings ratio than Xunlei, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xunlei$462.41M0.66$1.05B-$1.24N/A
Thryv$785.02M0.09$310K-$0.37N/A

In the previous week, Thryv had 2 more articles in the media than Xunlei. MarketBeat recorded 3 mentions for Thryv and 1 mentions for Xunlei. Thryv's average media sentiment score of 0.51 beat Xunlei's score of 0.00 indicating that Thryv is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Xunlei
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Thryv
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Thryv has a consensus price target of $8.50, suggesting a potential upside of 453.75%. Given Thryv's stronger consensus rating and higher possible upside, analysts plainly believe Thryv is more favorable than Xunlei.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Xunlei
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Thryv
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

Thryv has a net margin of -2.27% compared to Xunlei's net margin of -15.25%. Xunlei's return on equity of 0.62% beat Thryv's return on equity.

Company Net Margins Return on Equity Return on Assets
Xunlei-15.25% 0.62% 0.52%
Thryv -2.27%-7.36%-2.36%

Summary

Thryv beats Xunlei on 9 of the 16 factors compared between the two stocks.

How does Thryv compare to Silvaco Group?

Thryv (NASDAQ:THRY) and Silvaco Group (NASDAQ:SVCO) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Thryv has a net margin of -2.27% compared to Silvaco Group's net margin of -30.43%. Thryv's return on equity of -7.36% beat Silvaco Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Thryv-2.27% -7.36% -2.36%
Silvaco Group -30.43%-15.29%-10.02%

96.4% of Thryv shares are owned by institutional investors. 10.5% of Thryv shares are owned by company insiders. Comparatively, 47.9% of Silvaco Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Thryv presently has a consensus price target of $8.50, suggesting a potential upside of 453.75%. Silvaco Group has a consensus price target of $12.67, suggesting a potential upside of 37.38%. Given Thryv's higher possible upside, research analysts plainly believe Thryv is more favorable than Silvaco Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thryv
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
Silvaco Group
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80

In the previous week, Thryv and Thryv both had 3 articles in the media. Silvaco Group's average media sentiment score of 0.93 beat Thryv's score of 0.51 indicating that Silvaco Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Thryv
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Silvaco Group
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Thryv has higher revenue and earnings than Silvaco Group. Silvaco Group is trading at a lower price-to-earnings ratio than Thryv, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thryv$785.02M0.09$310K-$0.37N/A
Silvaco Group$63.06M4.96-$41.21M-$0.72N/A

Thryv has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Silvaco Group has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market.

Summary

Thryv beats Silvaco Group on 10 of the 16 factors compared between the two stocks.

How does Thryv compare to CS Disco?

Thryv (NASDAQ:THRY) and CS Disco (NYSE:LAW) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Thryv presently has a consensus price target of $8.50, indicating a potential upside of 453.75%. CS Disco has a consensus price target of $8.00, indicating a potential upside of 93.24%. Given Thryv's higher probable upside, research analysts clearly believe Thryv is more favorable than CS Disco.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thryv
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
CS Disco
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Thryv has a net margin of -2.27% compared to CS Disco's net margin of -24.20%. Thryv's return on equity of -7.36% beat CS Disco's return on equity.

Company Net Margins Return on Equity Return on Assets
Thryv-2.27% -7.36% -2.36%
CS Disco -24.20%-26.58%-19.89%

In the previous week, Thryv had 1 more articles in the media than CS Disco. MarketBeat recorded 3 mentions for Thryv and 2 mentions for CS Disco. CS Disco's average media sentiment score of 1.75 beat Thryv's score of 0.51 indicating that CS Disco is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Thryv
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CS Disco
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Thryv has higher revenue and earnings than CS Disco. CS Disco is trading at a lower price-to-earnings ratio than Thryv, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thryv$785.02M0.09$310K-$0.37N/A
CS Disco$156.85M1.71-$44.37M-$0.63N/A

96.4% of Thryv shares are held by institutional investors. Comparatively, 58.1% of CS Disco shares are held by institutional investors. 10.5% of Thryv shares are held by insiders. Comparatively, 16.8% of CS Disco shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Thryv has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, CS Disco has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market.

Summary

Thryv beats CS Disco on 10 of the 15 factors compared between the two stocks.

How does Thryv compare to Commerce.com?

Commerce.com (NASDAQ:CMRC) and Thryv (NASDAQ:THRY) are both small-cap technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

Commerce.com has a net margin of -1.66% compared to Thryv's net margin of -2.27%. Commerce.com's return on equity of 20.49% beat Thryv's return on equity.

Company Net Margins Return on Equity Return on Assets
Commerce.com-1.66% 20.49% 2.92%
Thryv -2.27%-7.36%-2.36%

Commerce.com presently has a consensus target price of $4.17, suggesting a potential upside of 29.60%. Thryv has a consensus target price of $8.50, suggesting a potential upside of 453.75%. Given Thryv's stronger consensus rating and higher possible upside, analysts plainly believe Thryv is more favorable than Commerce.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Commerce.com
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.71
Thryv
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

In the previous week, Thryv had 2 more articles in the media than Commerce.com. MarketBeat recorded 3 mentions for Thryv and 1 mentions for Commerce.com. Thryv's average media sentiment score of 0.51 beat Commerce.com's score of 0.00 indicating that Thryv is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Commerce.com
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Thryv
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

79.2% of Commerce.com shares are owned by institutional investors. Comparatively, 96.4% of Thryv shares are owned by institutional investors. 2.7% of Commerce.com shares are owned by company insiders. Comparatively, 10.5% of Thryv shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Commerce.com has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, Thryv has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market.

Thryv has higher revenue and earnings than Commerce.com. Commerce.com is trading at a lower price-to-earnings ratio than Thryv, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Commerce.com$342.35M0.78-$19.34M-$0.07N/A
Thryv$785.02M0.09$310K-$0.37N/A

Summary

Thryv beats Commerce.com on 10 of the 16 factors compared between the two stocks.

How does Thryv compare to Drugs Made In America Acquisition?

Thryv (NASDAQ:THRY) and Drugs Made In America Acquisition (NASDAQ:DMAA) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

96.4% of Thryv shares are owned by institutional investors. 10.5% of Thryv shares are owned by insiders. Comparatively, 0.9% of Drugs Made In America Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Thryv currently has a consensus target price of $8.50, suggesting a potential upside of 453.75%. Given Thryv's stronger consensus rating and higher probable upside, equities analysts clearly believe Thryv is more favorable than Drugs Made In America Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thryv
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
Drugs Made In America Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Drugs Made In America Acquisition has a net margin of 0.00% compared to Thryv's net margin of -2.27%. Drugs Made In America Acquisition's return on equity of 0.00% beat Thryv's return on equity.

Company Net Margins Return on Equity Return on Assets
Thryv-2.27% -7.36% -2.36%
Drugs Made In America Acquisition N/A N/A N/A

In the previous week, Thryv had 3 more articles in the media than Drugs Made In America Acquisition. MarketBeat recorded 3 mentions for Thryv and 0 mentions for Drugs Made In America Acquisition. Thryv's average media sentiment score of 0.51 beat Drugs Made In America Acquisition's score of 0.00 indicating that Thryv is being referred to more favorably in the media.

Company Overall Sentiment
Thryv Positive
Drugs Made In America Acquisition Neutral

Thryv has higher revenue and earnings than Drugs Made In America Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thryv$785.02M0.09$310K-$0.37N/A
Drugs Made In America AcquisitionN/AN/AN/AN/AN/A

Summary

Thryv beats Drugs Made In America Acquisition on 8 of the 11 factors compared between the two stocks.

Get Thryv News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRY vs. The Competition

MetricThryvSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$67.55M$16.15B$31.66B$13.24B
Dividend YieldN/A3.43%2.75%15.88%
P/E Ratio-4.11143.8281.3626.05
Price / Sales0.091,278.50589.1889.39
Price / Cash1.1945.1349.1351.25
Price / Book0.308.788.126.31
Net Income$310K$431.57M$702.36M$361.43M
7 Day Performance-15.08%261.97%114.86%-1.67%
1 Month Performance-19.15%165.54%74.28%-3.94%
1 Year Performance-87.14%-0.50%168.48%2.77%

Thryv Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRY
Thryv
3.9191 of 5 stars
$1.52
-3.2%
$8.50
+459.2%
-86.6%$67.55M$785.02MN/A2,729
XNET
Xunlei
0.52 of 5 stars
$5.03
+0.3%
N/A-52.4%$320.36M$462.41MN/A1,306
SVCO
Silvaco Group
2.8569 of 5 stars
$8.31
-1.8%
$12.67
+52.5%
+65.8%$281.49M$63.06MN/A406
LAW
CS Disco
3.1066 of 5 stars
$4.31
+1.3%
$8.00
+85.8%
-31.6%$279.48M$156.85MN/A577
CMRC
Commerce.com
2.7196 of 5 stars
$3.24
+2.7%
$4.17
+28.8%
-33.9%$268.05M$342.35MN/A1,079

Related Companies and Tools


This page (NASDAQ:THRY) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners